Inflationary storm clouds will continue to buffet global pharma industry in 2023
Pharmaceutical Technology
JANUARY 16, 2023
The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets. However, a looming risk on the horizon in 2023 is that the economic pain may produce downstream effects on global pharmaceutical supply chain networks.
Let's personalize your content